Table 3. Prevalence of raised total cholesterol level and metabolic syndrome, and their determinants WHO STEPS survey, Ethiopia 2015.

Variables		Prevalence of raised total Cholesterol (> = 200 mg/dl)		Prevalence of metabolic syndrome *
		n	%	n	%
Sex	Male	165	3.9%	114	1.8%
	Female	421	6.8%	643	8.6%
	Total	586	5.2	757	4.8%
Age Group	15–24	84	4.1%	59	1.6%
	25–34	131	4.3%	144	3.6%
	35–44	141	6.2%	219	7.8%
	45–54	122	8.3%	171	9.8%
	55–64	81	8.9%	114	10.1%
	65+	27	3.3%	50	10.8%
	Total	586	5.2	757	4.8%
Locality	Urban	230	7.1%	437	11.7%
	Rural	356	4.8%	320	3.2%
Current alcohol use	Yes	236	7.1%	236	4.3%
	No	17	4.7%	47	8.3%
BMI	Underweight	99	4.8%	36	1.0%
	Normal	372	4.9%	374	3.9%
	Overweight	83	11.3%	240	29.7%
	Obese	29	8.4%	107	41.7%
Quartiles of income	Q1	76	4.2%	119	4.5%
	Q2	83	3.3%	123	4.6%
	Q3	112	6.1%	116	4.7%
	Q4	132	6.7%	188	6.8%
Physical Activity Level	Low level	140	6.8%	240	9.9%
	Moderate Level	121	6.7%	159	6.0%
	High Level	322	4.6%	356	3.6%
Raised waist circumference	Normal	371	4.6%	0	0.0%
	Raised	214	9.4%	757	39.8%
Waist hip ratio level	Normal WHR	339	5.0%	181	1.3%
	Raised WHR	246	5.8%	576	14.1%
Raised Blood Pressure	Normal	412	4.9%	278	2.1%
	Raised	174	7.1%	479	18.8%
Raised blood glucose (> = 126 mg/dl)	No	498	3.8%	663	4.3%
	Yes	88	46.5%	94	18.0%
Total Cholesterol level	<200	NA	NA	631	4.7%
	> = 200	NA	NA	122	12.3%
	Total	NA	NA	753	4.8%

*Metabolic syndrome (MetS) based on with the IDF criteria, subjects were classified as having MetS if participants had abdominal obesity (defined as waist circumference of ≥94 cm for men and ≥80 cm women) plus two of any of the following risk factors: (1) raised TG level (≥150 mg/dL); (2) reduced HDLC (<40 mg/dL in males and <50 mg/dL in females); (3) raised blood pressure (systolic BP ≥130 or diastolic BP ≥85 mmHg) or treatment of previously diagnosed hypertension; (4) raised FG (≥100 mg/dL